$DLB

Nicholson Ryan sold $22K of DLB

Nicholson Ryan (VP, CAO and Corp. Controller) sold 357 shares of Dolby Laboratories, Inc. (DLB) at $60.63 on 2026-08-04.

Original reporting
SEC EDGAR · Nicholson Ryan
Published Aug 6, 2026, 9:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The only new fact is the reported open-market sale by VP, CAO and Corp. Controller Nicholson Ryan (357 shares at $60.63). This is typically a low-signal event for traders unless unusually large or paired with other disclosures.

02

Market read

Traders may note the insider sale for sentiment, but there is no accompanying guidance, legal, or operational catalyst in the text.

03

What to watch

The article does not provide context on total holdings, prior sales frequency, or whether other insiders sold/bought around the same time, limiting signal strength.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-08-06, covering a sale executed 2026-08-04.

Background

The article is an SEC Form 4 insider transaction disclosure for Dolby Laboratories, Inc.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby Laboratories insider Nicholson Ryan sold 357 shares at $60.63 on 2026-08-04, per a new SEC Form 4 filing.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment and positioning rather than fundamentals.

Evidence & confidence

The disclosure is a Form 4 insider transaction, not earnings, guidance, or a corporate event. The sale size is modest and the filing provides no new company-specific operational or financial information.

Market effects

Minimal. Insider selling in a single name does not materially reset sector expectations.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-scheduled liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative information.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Nicholson Ryan

    VP, CAO and Corp. Controller who sold 357 shares.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co